Madrigal Pharmaceuticals, Inc. (MDGL)

497.34 -12.70 (-2.49%) USD  |  NASDAQ  |  May 11, 14:14
More

Madrigal Pharmaceuticals Stock Based Compensation (TTM)

Stock Based Compensation (TTM) Chart

View Stock Based Compensation (TTM) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Based Compensation (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Stock Based Compensation (TTM) Range, Past 5 Years

View Stock Based Compensation (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Based Compensation (TTM) Benchmarks

View Stock Based Compensation (TTM) Benchmarks
Start Trial
Insmed, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade
Altimmune, Inc. Upgrade